- ICH GCP
- Amerikanska kliniska prövningsregistret
- Search trials
Sök i kliniska prövningar för: JNJ 42756493
Totalt 880 resultat
-
Johnson & Johnson Pharmaceutical Research & Development...Avslutad
-
Janssen Research & Development, LLCAvslutad
-
Johnson & Johnson Pharmaceutical Research & Development...Avslutad
-
Janssen Research & Development, LLCAvslutad
-
Yale UniversityPfizer; Avid RadiopharmaceuticalsAvslutadDiabetes mellitus, typ 1Förenta staterna
-
Johnson & Johnson Pharmaceutical Research & Development...Indragen
-
Janssen Research & Development, LLCThe Scripps Research InstituteIndragen
-
Johnson & Johnson Pharmaceutical Research & Development...Avslutad
-
Johnson & Johnson Pharmaceutical Research & Development...Avslutad
-
Furiex Pharmaceuticals, IncAvslutadKomplicerade hud- och hudstrukturinfektionerFörenta staterna
-
Furiex Pharmaceuticals, IncAvslutadCommunity-acquired Bacterial Pneumonia (CABP)Förenta staterna, Kanada, Colombia, Tyskland, Ungern, Polen
-
Texas Tech UniversityNational Cancer Institute (NCI); American Cancer Society, Inc.AvslutadArsenisk melanos | Arsenisk keratos | Arseniska cancer | Arsenikos | Arsenikexponering | Arseniktoxicitet | ArsenikförgiftningBangladesh
-
Johnson & Johnson Pharmaceutical Research & Development...Avslutad
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaAvslutadBröstneoplasmer | LymfödemKanada
-
Johnson & Johnson Pharmaceutical Research & Development...Avslutad
-
Johnson & Johnson Pharmaceutical Research & Development...Avslutad
-
Johnson & Johnson Pharmaceutical Research & Development...Avslutad
-
Johnson & Johnson Pharmaceutical Research & Development...AvslutadFriska | Farmakokinetik | Läkemedelsinteraktioner
-
Johnson & Johnson Pharmaceutical Research & Development...Avslutad
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., BelgiumAvslutadFarmakokinetik | Avancerade maligniteter | Fasta maligniteter | Proteinkinashämmare | Maximal tolererad dos | Antineoplastiska protokoll | Klinisk prövning, fas 1
-
Johnson & Johnson Pharmaceutical Research & Development...AvslutadAttention Deficit Hyperactivity Disorder | Attention Deficit Disorders med hyperaktivitet
-
Johnson & Johnson Pharmaceutical Research & Development...AvslutadAttention Deficit Hyperactivity Disorder | Attention Deficit Disorders med hyperaktivitet
-
Johnson & Johnson Pharmaceutical Research & Development...Avslutad
-
Johnson & Johnson Pharmaceutical Research & Development...Avslutad
-
Johnson & Johnson Pharmaceutical Research & Development...Avslutad
-
SanofiAvslutadMajor depressiv sjukdomFörenta staterna, Kanada
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Avslutad
-
AttenuonProstate Cancer Clinical Trials ConsortiumOkänd
-
AttenuonOkänd
-
National Center for Research Resources (NCRR)Stanford UniversityOkändTvångssyndromFörenta staterna